Page last updated: 2024-09-03

uh 301 and way 100135

uh 301 has been researched along with way 100135 in 1 studies

Compound Research Comparison

Studies
(uh 301)
Trials
(uh 301)
Recent Studies (post-2010)
(uh 301)
Studies
(way 100135)
Trials
(way 100135)
Recent Studies (post-2010) (way 100135)
5208143034

Protein Interaction Comparison

ProteinTaxonomyuh 301 (IC50)way 100135 (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.0339
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)1.491
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0339
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)1.491
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)1.491

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arborelius, L; Grillner, P; Hacksell, U; Hertel, P; Höök, BB; Nomikos, GG; Svensson, TH1

Other Studies

1 other study(ies) available for uh 301 and way 100135

ArticleYear
5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
    Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 352, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Citalopram; Electrophysiology; Extracellular Space; Male; Neurons; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synaptic Transmission

1995